MELTECH
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Sept 2024)
What this means for you
Registered since 16 Oct 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Oct 2028: the §8 & §9 renewal).
Record
- Serial number
- 87614404
- Registration number
- 5583912
- Mark type
- Word mark
- Filed
- 19 Sept 2017
- Published for opposition
- 31 Jul 2018
- Registered
- 16 Oct 2018
- Next maintenance filing
- §8 & §9 renewal, due by 16 Oct 2028 (grace period to 16 Apr 2029)
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Tablets and medicaments for the treatment of genetic, [ cardiovascular, ] central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, [ dermatological, ] infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, [ ophthalmologic, ] psychiatric, respiratory, [ urogenital, urological, erectile dysfunction, sexual dysfunction, ] gynecology, obstetric, [ pediatric, hematologic, ] oncological, fungal and viral diseases and disorders
Owner
- Dexcel Pharma Technologies Ltd., Jerusalem, IL
- Dexcel Pharma Technologies Ltd., 3060000 Or Akiva, IL
- Dexcel Pharma Technologies Ltd., 3060000 Or Akiva, IL
Prosecution history
- 30 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Sept 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Mar 2024 — TEAS SECTION 8 & 15 RECEIVED
- 16 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 31 Jul 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jul 2018 — PUBLISHED FOR OPPOSITION
- 11 Jul 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jun 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jun 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2018 — ASSIGNED TO LIE
- 11 Jun 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Dec 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED